FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely ophthalmology. The maximum corrected visual acuity is determined, as well as the criteria for short-wave autofluorescence: the presence of additional hypo-autofluorescent or hyperautofluorescent points or areas outside the main focus and the brightness of hyperautofluorescence. Then the probability of the patient having central serous chorioretinopathy and vitelliform dystrophies is calculated using the formula. With B from 0.5 to 1.0, a conclusion is made about the probable presence of vitelliform dystrophies in the patient, and with B from 0.0 to 0.49 - about the probable presence of chronic central serous chorioretinopathy.
EFFECT: method allows to optimize the differential diagnosis of chronic central serous chorioretinopathy and vitelliform dystrophies in adult patients.
1 cl, 4 dwg, 2 tbl, 2 ex
Authors
Dates
2022-01-24—Published
2021-05-21—Filed